T細胞リンパ腫(T-Cell Lymphomas):治療薬開発パイプライン動向2015

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVP501689)
◆英語タイトル:T-Cell Lymphomas-Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVP501689
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[T細胞リンパ腫(T-Cell Lymphomas):治療薬開発パイプライン動向2015]についてメールでお問い合わせはこちら
本調査レポートでは、世界におけるT細胞リンパ腫(T-Cell Lymphomas)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、T細胞リンパ腫(T-Cell Lymphomas)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・T細胞リンパ腫(T-Cell Lymphomas)の概要

・T細胞リンパ腫(T-Cell Lymphomas)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・T細胞リンパ腫(T-Cell Lymphomas)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・T細胞リンパ腫(T-Cell Lymphomas)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ T-Cell Lymphomas-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under T-Cell Lymphomas. This report provides information on the therapeutic development based on the T-Cell Lymphomas dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of T-Cell Lymphomas
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the T-Cell Lymphomas pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for T-Cell Lymphomas and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• T-Cell Lymphomas Overview
• T-Cell Lymphomas Pipeline Therapeutics
• T-Cell Lymphomas Therapeutics under Development by Companies
• T-Cell Lymphomas Late Stage Products (Filed and Phase III)
– Comparative Analysis
• T-Cell Lymphomas Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• T-Cell Lymphomas Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• T-Cell Lymphomas Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• T-Cell Lymphomas – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• T-Cell Lymphomas – Discontinued Products
• T-Cell Lymphomas – Dormant Products
• Companies Involved in Therapeutics Development for T-Cell Lymphomas
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for T-Cell Lymphomas, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• T-Cell Lymphomas Assessment by Monotherapy Products
• T-Cell Lymphomas Assessment by Combination Products
• T-Cell Lymphomas Assessment by Route of Administration
• T-Cell Lymphomas Assessment by Stage and Route of Administration
• T-Cell Lymphomas Assessment by Molecule Type
• T-Cell Lymphomas Assessment by Stage and Molecule Type
• T-Cell Lymphomas Therapeutics – Discontinued Products
• T-Cell Lymphomas Therapeutics – Dormant Products
• Products under Development by Companies, 2015


List of Figures
• Number of Products under Development for T-Cell Lymphomas, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• T-Cell Lymphomas Assessment by Monotherapy Products
• T-Cell Lymphomas Assessment by Combination Products
• T-Cell Lymphomas Assessment by Route of Administration
• T-Cell Lymphomas Assessment by Stage and Route of Administration
• T-Cell Lymphomas Assessment by Molecule Type
• T-Cell Lymphomas Assessment by Stage and Molecule Type


*** レポートのキーワード ***

T細胞リンパ腫(T-Cell Lymphomas)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • Lotus Pharmaceuticals, Inc.(製薬・医療分野):企業M&A動向
    Summary Lotus Pharmaceuticals, Inc. (Lotus) is a privately held pharmaceutical company which carries out the development, manufacture and distribution of prescription drugs and pharmaceutical products. It offers products for the treatment of asthma, diabetes and cerebro-cardiovascular diseases. The …
  • 世界のトラディショナルベッド市場2016
    Notes:Production, means the output of Traditional Bed Revenue, means the sales value of Traditional Bed This report studies Traditional Bed in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, p …
  • 血腫の世界市場:企業概要・規模・シェア・成長・動向・予測(~2024年)
    The Global Hemostats Market is accounted to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024. The major factors driving the growth of this market are the increasing number of surgeries, increasing healthcare expenditure, technological …
  • 褥瘡防止フォームマットレスの世界市場:販売動向2018
    This report studies the global Anti-decubitus Foam Mattresses market status and forecast, categorizes the global Anti-decubitus Foam Mattresses market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, S …
  • 日本のフットウェア市場(~2019)
    The report Footwear Market in Japan to 2019 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for footwear in Japan. The research includes historic data from 2008 to 2014 and forecasts until 2019 which makes the repo …
  • 世界の炭素繊維強化ポリマー鉄筋市場2016
    Notes:Production, means the output of Carbon Fiber Reinforced Polymer Rebar Revenue, means the sales value of Carbon Fiber Reinforced Polymer Rebar This report studies Carbon Fiber Reinforced Polymer Rebar in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, …
  • United States Lime & Minerals, Inc. (USLM):企業概要及びSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "United States Lime & Minerals, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World M …
  • 世界及び中国のトリエチレンジアミン市場2016
    The 'Global and Chinese Triethylenediamine Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Triethylenediamine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Triethylenediamine …
  • 世界及び中国のジエチルフタレート(DEP)市場2017
    The 'Global and Chinese Diethyl phthalate (DEP) Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Diethyl phthalate (DEP) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Diet …
  • 電動搾乳器の世界市場
    About Electric Breast Pumps An electrical device powered by electricity from the grid or batteries and used for extracting milk from the breasts of a lactating woman is known as an electrical breast pump. The device assists in triggering the milk ejection response or let-down reflex of lactating mot …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVP501689 )"T細胞リンパ腫(T-Cell Lymphomas):治療薬開発パイプライン動向2015" (英文:T-Cell Lymphomas-Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。